BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30168167)

  • 1. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
    Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
    Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
    Dano H; Altinay S; Arnould L; Bletard N; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchió C; Martinez DM; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban AM; Sinke R; Stanciu-Pop CM; Stobbe C; van Deurzen CHM; Van de Vijver K; Van Rompuy AS; Verschuere S; Vincent-Salomon A; Wen H; Bouzin C; Galant C; Van Bockstal MR
    Mod Pathol; 2020 Mar; 33(3):354-366. PubMed ID: 31534203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in grading of ductal carcinoma in situ among an international group of pathologists.
    van Seijen M; Jóźwiak K; Pinder SE; Hall A; Krishnamurthy S; Thomas JS; Collins LC; Bijron J; Bart J; Cohen D; Ng W; Bouybayoune I; Stobart H; Hudecek J; Schaapveld M; Thompson A; Lips EH; Wesseling J;
    J Pathol Clin Res; 2021 May; 7(3):233-242. PubMed ID: 33620141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
    Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
    Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Grade Ductal Carcinoma In Situ.
    Alghamdi SA; Krishnamurthy K; Garces Narvaez SA; Algashaamy KJ; Aoun J; Reis IM; Recine MA; Jorda M; Poppiti RJ; Gomez-Fernandez CR
    Am J Clin Pathol; 2020 Feb; 153(3):360-367. PubMed ID: 31769792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver Variability in Ductal Carcinoma In Situ of the Breast.
    Van Bockstal MR; Berlière M; Duhoux FP; Galant C
    Am J Clin Pathol; 2020 Oct; 154(5):596-609. PubMed ID: 32566938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
    Groen EJ; Hudecek J; Mulder L; van Seijen M; Almekinders MM; Alexov S; Kovács A; Ryska A; Varga Z; Andreu Navarro FJ; Bianchi S; Vreuls W; Balslev E; Boot MV; Kulka J; Chmielik E; Barbé E; de Rooij MJ; Vos W; Farkas A; Leeuwis-Fedorovich NE; Regitnig P; Westenend PJ; Kooreman LFS; Quinn C; Floris G; Cserni G; van Diest PJ; Lips EH; Schaapveld M; Wesseling J;
    Breast Cancer Res Treat; 2020 Oct; 183(3):759-770. PubMed ID: 32734520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast.
    Agahozo MC; van Bockstal M; Westenend PJ; Galant C; Lambein K; Reisenbichler E; Sinke R; Wong S; van Deurzen CHM
    J Mammary Gland Biol Neoplasia; 2021 Dec; 26(4):367-375. PubMed ID: 35076865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
    Sneige N; Lagios MD; Schwarting R; Colburn W; Atkinson E; Weber D; Sahin A; Kemp B; Hoque A; Risin S; Sabichi A; Boone C; Dhingra K; Kelloff G; Lippman S
    Hum Pathol; 1999 Mar; 30(3):257-62. PubMed ID: 10088542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
    Van Bockstal M; Lambein K; Smeets A; Slembrouck L; Neven P; Nevelsteen I; Weltens C; Van Limbergen E; Christiaens MR; Van Ongeval C; Wildiers H; Libbrecht L; Floris G
    Eur J Surg Oncol; 2019 Apr; 45(4):550-559. PubMed ID: 30454971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
    Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
    Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients.
    Perez AA; Balabram D; Salles Mde A; Gobbi H
    Diagn Pathol; 2014 Dec; 9():227. PubMed ID: 25471940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.
    Schuh F; Biazús JV; Resetkova E; Benfica CZ; Ventura Ade F; Uchoa D; Graudenz M; Edelweiss MI
    Diagn Pathol; 2015 Jul; 10():93. PubMed ID: 26159429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?
    Tan PH; Ho BC; Selvarajan S; Yap WM; Hanby A
    J Clin Pathol; 2005 Jul; 58(7):705-9. PubMed ID: 15976336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast.
    Stanciu-Pop C; Nollevaux MC; Berlière M; Duhoux FP; Fellah L; Galant C; Van Bockstal MR
    Virchows Arch; 2021 Jul; 479(1):33-43. PubMed ID: 33502600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
    Tozbikian G; Brogi E; Vallejo CE; Giri D; Murray M; Catalano J; Olcese C; Van Zee KJ; Wen HY
    Int J Surg Pathol; 2017 Apr; 25(2):100-107. PubMed ID: 27481892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
    Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
    JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consultation in breast surgical pathology: interobserver diagnostic variability of atypical intraductal proliferative lesions].
    Perez AA; Balabram D; Salles Mde A; Gobbi H
    Rev Bras Ginecol Obstet; 2013 Apr; 35(4):164-70. PubMed ID: 23752581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic challenge of low-grade ductal carcinoma in situ.
    Onega T; Weaver DL; Frederick PD; Allison KH; Tosteson ANA; Carney PA; Geller BM; Longton GM; Nelson HD; Oster NV; Pepe MS; Elmore JG
    Eur J Cancer; 2017 Jul; 80():39-47. PubMed ID: 28535496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.